| abstract |
The invention is directed to the use of deoxypeganine, as a free base or acid addition salt, for the treatment of cerebral, central nerve or psychiatric symptoms, defunctional manifestations or disorders which occur through ingestion of psychotropic substances, as a consequence of accidental or chronic abuse of addictive substances, drugs or medicines, or as a side effect of use, in particular repeated or prolonged, as intended as medicinal products, or as an effect of use, in particular repeated or prolonged, of medicines, which use is not intended use of said medicines, or as a result of acute poisoning with psychotropically toxic substances, or as a result of chronic exposure to psychotropically active toxic substances in humans or other vertebrates. |